Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Journal of Molecular Medicine (Berlin, Germany)|June 8, 2014
Glycolytic genes in cancer cells are more than glucose metabolic regulatorsZhe-Yu Hu, Lanbo Xiao, Ann M Bode, et al.Journal of Translational Medicine|August 25, 2009
ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathwayZhe-Yu Hu, Jian Sun, Xiao-Feng Zhu, et al.Frontiers in Endocrinology|December 15, 2022
Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBCYu Tang, Jing Li, Binliang Liu, et al.Frontiers in Immunology|June 14, 2024
Case report: Pilomatrix carcinoma with PDL1 expression and <i>CDKN2A</i> aberrantAyinuer Abula, Sheng-Qiang Ma, Sisi Wang, et al.Annals of Translational Medicine|September 29, 2022
The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort studyCan Tian, Jianbo Yang, Ning Xie, et al.Journal of Drug Targeting|January 8, 2019
ANGPTL3: a novel biomarker and promising therapeutic targetShuang Jiang, Guo-Hui Qiu, Neng Zhu, et al.Clinical Breast Cancer|June 11, 2018
Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone ReceptorZhe-Yu Hu, Huawu Xiao, Mengjia Xiao, et al.Journal of Translational Medicine|January 17, 2019
Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patientsJingyu Liu, Jing Li, Hui Wang, et al.Oncology Reports|June 11, 2009
Apogossypolone inhibits cell growth by inducing cell cycle arrest in U937 cellsJian Sun, Zhi-Ming Li, Zhe-Yu Hu, et al.Chinese Journal of Cancer|January 4, 2011
Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen speciesZhe-Yu Hu, Jing Wang, Gang Cheng, et al.Pageof 4